eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2005, Volume 1, Issue 4 : 418-423 doi: ijmmas.2005.418.423
Research Article
Hepatoprotective and in vivo Antioxidant Effects of Careya arborea against Carbon tetrachloride Induced Liver Damage in Rats
Published
March 30, 2005
Abstract

The present study was carried out to evaluate the hepatoprotective and antioxidant effect of the Methanol Extract of Careya arborea Roxb (MECA) (Family- Myrtaceae) stem bark in Wistar albino rats. The different groups of animals were administered with carbon tetrachloride (CCl4) (30 % CCl4, 1 mL Kg 1 b. wt. in liquid paraffin 3 doses (i.p.) at 72 h interval). The MECA at the doses of 50, 100 and 200 mg Kg 1 and silymarin 25 mg Kg 1were administered to the CCl4 treated rats. The effect of MECA and silymarin on serum transaminase (GOT, GPT), Alkaline Phosphates (ALP), bilirubin, uric acid and total protein were measured in the rats induced hepatotoxicity by CCl4. Further, the effects of the extract on Lipid Peroxidation (LPO), enzymatic antioxidant (Superoxide Dismutase (SOD) and Catalase (CAT)), and nonenzymatic antioxidant (Glutathione (GSH), vitamin C and vitamin E) were estimated. The MECA and silymarin produced significant (p < 0.05) hepatoprotective effect by decreasing the activity of serum enzymes, bilirubin, uric acid, and lipid peroxidation and significantly (p < 0.05) increased the levels of SOD, CAT, GSH, vitamin C, vitamin E and protein in a dose dependent manner. From these results, it was suggested that MECA possess potent hepatoprotective and antioxidant properties.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Smart Hospitals and Healthcare Automation: Transforming Healthcare Delivery Through Artificial Intelligence, Internet of Medical Things, and Intelligent Automation
16-20
Internet of Medical Things in Healthcare Delivery: Enhancing Patient Care, Remote Monitoring, and Healthcare System Efficiency
6-10
Heart Failure Management and Patient Quality of Life: A Multicenter Assessment of Clinical Outcomes, Self-Care Practices, and Health-Related Quality of Life
11-15
Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients
41-45
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.